Page 25 - Bharat Biotech

'It's nightmarish': Uphill task as Bharat Biotech gears for vaccine rollout

Bharat has already produced about 10 million doses of its Covaxin shot, ahead of an anticipated roll out by the middle of next year

Bharat Biotech halfway through in one of country's largest phase-3 trials

Pfizer yet to submit data to regulator while Serum Institute has provided all additional information for emergency use authorisation

Ocugen to co-develop Bharat Biotech's Covid-19 vaccine candidate for US

Drug developer Ocugen said it had partnered with Bharat Biotech to co-develop the India-based company's Covid-19 vaccine candidate for the US market

Bharat Biotech recruits 13,000 volunteers for Covaxin Phase 3 trials

Bharat Biotech announced successful recruitment of 13,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for Phase III clinical trial of its Covid vaccine Covaxin

Inactivated Covid vaccine safest with lesser bad reactions: Bharat Biotech

Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine and DNA-based vaccine, the inactivated vaccines being developed by it for Covid-19 are safest

Paediatric coronavirus vaccine work may begin in India by mid of 2021

Bharat Biotech is testing its whole virus inactivated vaccine, a tech in use for decades, on subjects aged 12 years and above

Covaxin facing shortage of volunteers for phase 3 trials, says AIIMS

The Phase III clinical trial for Bharat Biotech's vaccine candidate Covaxin is witnessing a shortage of volunteer participation, with a high refusal rate of 70% to 80%, a senior AIIMS doctor said

Covaxin's phase 1 trial data shows robust response: Bharat Biotech

Bharat Biotech had recently sought an accelerated approval from the regulator based on phase 1 and phase 2 studies

States told to estimate and strengthen cold chain for vaccine: Health secy

In all, 29,000 cold chain points, 240 walk-in coolers, 70 walk-in freezers, 45,000 ice-lined refrigerators, 41,000 deep freezers and 300 solar refrigerators are to be used

Seven important Coronavirus vaccine updates that you need to know

Listen to the podcast to know about the current status of the Covid-19 vaccine in India and other parts of the world

Recruited 8,000 volunteers already for phase 3 trials: Bharat Biotech head

The company says they are '200% transparent' about serious adverse events with regulator

World is watching India for 'safe' Covid vaccine, but are we ready?

As the world is watching India for cheap and safe Covid-19 vaccine as soon as possible, how much the country is ready to deliver on promises, with challenges galore? Despite having one of the largest universal immunization programmes (UIPs), lack of cold chain may prove to be one of the biggest challenges for India in Covid-19 vaccine distribution. Watch the video to get a sense of the where we stand on vaccines today.

Curbs may have to be maintained after vaccination: Ramanan Laxminarayan

Laxminarayan, in an interview with Geetika Srivastava, says that masks and small gatherings may stick around for a while

Review panel asks vaccine makers to submit more data to get authorisation

Experts ask Bharat Biotech for phase 3 data, Serum's UK approval status

Provide more safety data on Covid-19 vaccine: SEC to Serum, Bharat Biotech

The application submitted by the Pfizer was not discussed at the SEC meeting as the company has requested for more time for giving its presentation

Kiran Mazumdar-Shaw: Will take Covid vaccine; confident on safety, efficacy

Bharat Biotech, Serum Institute of India and Pfizer have applied to the Drugs Controller General of India seeking emergency use authorisation for their Covid-19 vaccine candidates

Coronavirus LIVE: Covid-19 situation in Delhi stabilising, says NITI Aayog

Coronavirus live updates: At 18,55,341, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 894,004, Andhra Pradesh 872,288, Tamil Nadu 791,552, and Kerala 639,664

Top headlines: Call for emergency use of Covaxin; tax officers face heat

From Bharat Biotech applying for emergency use of Covaxin to super-rich buying luxury products online like never before, here are top headlines this morning

Bharat Biotech applies for emergency use authorisation for Covaxin

The company is conducting a 26,000 subjects phase 3 efficacy trial in India to determine the efficacy of its candidate

Vaccine efficacy based on 2 doses: Bharat Biotech after Vij tests positive

Covaxin is an indigenously developed Covid-19 vaccine undergoing a trial on over 26,000 people across 25 sites in India to evaluate the efficacy of the vaccine candidate